Efficacy and Safety of Carbon-Ion Radiotherapy for Stage I Non-Small Cell Lung Cancer with Coexisting Interstitial Lung Disease

SIMPLE SUMMARY: Interstitial lung disease (ILD) is a risk factor for lung cancer, but the treatment options are often limited because of concerns that ILD may worsen with treatment. In this study, we analyzed whether the presence or absence of ILD affects the outcome of carbon-ion radiotherapy (CIRT...

Descripción completa

Detalles Bibliográficos
Autores principales: Okano, Naoko, Kubo, Nobuteru, Yamaguchi, Koichi, Kouno, Shunichi, Miyasaka, Yuhei, Mizukami, Tatsuji, Shirai, Katsuyuki, Saitoh, Jun-ichi, Ebara, Takeshi, Kawamura, Hidemasa, Maeno, Toshitaka, Ohno, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391416/
https://www.ncbi.nlm.nih.gov/pubmed/34439358
http://dx.doi.org/10.3390/cancers13164204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391416/
https://www.ncbi.nlm.nih.gov/pubmed/34439358
http://dx.doi.org/10.3390/cancers13164204

Ejemplares similares